A single center's experience with pacemaker implantation after the Cox maze procedure for atrial fibrillation

Niv Ad1, Sari D Holmes2, Rabia Ali3

  • 1Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WVa.

Insights

Pacemaker implantation (PMI) after the Cox maze procedure (CM) for atrial fibrillation is less common than previously reported. When needed, PMI did not worsen patient outcomes or freedom from arrhythmia.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Electrophysiology

Background:

  • The Cox maze procedure (CM) is a recognized treatment for atrial fibrillation (AF).
  • Recent studies indicated a high rate of pacemaker implantation (PMI) after CM.
  • The actual incidence and impact of PMI post-CM require further investigation.

Purpose of the Study:

  • To determine the incidence of in-hospital pacemaker implantation (PMI) following the Cox maze procedure (CM).
  • To identify risk factors associated with PMI after CM.
  • To evaluate the impact of PMI on short- and long-term outcomes after CM.

Main Methods:

  • A prospective analysis of 739 patients undergoing CM between 2005 and 2015.
  • Multivariable logistic regression to identify risk factors for PMI.
  • Propensity score matching to compare outcomes between CM patients and those without surgical ablation.

Main Results:

  • The in-hospital PMI rate was 7.0% (52 patients).
  • Sick sinus syndrome was the most common indication for PMI (67%).
  • Patients undergoing multiple valve procedures had a higher risk of PMI. Perioperative outcomes and freedom from arrhythmia were similar between patients with and without PMI.

Conclusions:

  • The incidence of PMI after CM is lower than previously suggested.
  • Indicated PMI following CM is not associated with increased morbidity or reduced freedom from atrial arrhythmia.
  • Enhanced surgeon training and postoperative management awareness may further minimize adverse events and reduce PMI rates.
Abstract

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
547
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
390
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
730